Answers are grounded in this paper and cite their sources.
OBJECTIVE: To evaluate the pharmacokinetics of a purified oral cannabidiol (CBD) capsule administered with and without food in adults with refractory epilepsy. METHODS: ratios between fed and fasting states were calculated. Seizure and adverse events information was collected. RESULTS: was observed. No adverse events were reported. SIGNIFICANCE: and can account for variability in bioavailability and overall drug exposure within patients with oral products.
No takes yet. Share an insight, caveat, or question.
Birnbaum et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: